The upgrade assists researchers with drug discovery and molecular design.
Karan Singhal#1394
We’re bringing new capabilities to GPT-Rosalind, a model series purpose-built for life sciences research at enterprise scale.
It brings GPT-5.5’s agentic coding and tool use together with stronger intelligence for drug discovery, analysis, design, and experimental workflows.
https://openai.com/index/introducing-new-capabilities-to-gpt-rosalind
Major upgrade to GPT-Rosalind, with much better intelligence for drug discovery, analysis, design, and experimental workflows:
We’re bringing new capabilities to GPT-Rosalind, a model series purpose-built for life sciences research at enterprise scale.
It brings GPT-5.5’s agentic coding and tool use together with stronger intelligence for drug discovery, analysis, design, and experimental workflows.
https://openai.com/index/introducing-new-capabilities-to-gpt-rosalind
The upgrade assists researchers with drug discovery and molecular design.
Karan Singhal#1394We’re bringing new capabilities to GPT-Rosalind, a model series purpose-built for life sciences research at enterprise scale.
It brings GPT-5.5’s agentic coding and tool use together with stronger intelligence for drug discovery, analysis, design, and experimental workflows.
https://openai.com/index/introducing-new-capabilities-to-gpt-rosalind
Positive users highlight GPT-Rosalind's potential for life sciences and drug discovery as a meaningful advancement, while negative users dismiss the upgrades as boring or low-quality.